Balanced news tone
News Sentiment
IRLAB-A sentiment intelligence
IRLAB Therapeutics AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
89/100 classification confidence.
directly relevant articles
high-authority source matches
+8.4% over one week, +12.6% over four weeks, trend inactive, and below fair value.
IRLAB Completes Registration of Rights Issue and Converts Interim Shares
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
IRLAB Completes Registration of Rights Issue and Converts Interim Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 14:11
- Source
- TipRanks
IRLAB’s rights issue is registered – conversion of BTA into shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 13:30
- Source
- TradingView
Irlab board member James Gamgort buys shares for just under SEK 0.3m
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 12:32
- Source
- marketscreener.com
IRLAB Raises SEK 76.5 Million in Oversubscribed Rights and Overallotment Issues
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- The Globe and Mail
IRLAB presents integrated analysis of mesdopetam data at international conference – confirms robust efficacy results in the Phase II studies
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- TradingView
The subscription period in IRLAB’s rights issue commences today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- TradingView
Report from the Extraordinary General Meeting of IRLAB Therapeutics AB
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- TradingView
IRLAB participates at Aktiedagarna in Stockholm on June 9.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- TradingView
Irlab's shares plummet 60% after Ipsen-partnered Parkinson's drug flunks phase 2 trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jan 2023 08:00
- Source
- Fierce Biotech